{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:26:12Z","timestamp":1789896372500,"version":"4.0.1"},"reference-count":65,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:p>This study evaluated the effects of aldose reductase inhibition on diabetes-induced oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation. In animal experiments, control and streptozotocin-induced diabetic rats were treated with or without the aldose reductase inhibitor (ARI) fidarestat (16 mg \u00b7 kg\u22121 \u00b7 day\u22121) for 6 weeks starting from induction of diabetes. Sorbitol pathway intermediate, but not glucose, accumulation in sciatic nerve and retina was completely prevented in diabetic rats treated with fidarestat. Sciatic motor nerve conduction velocity, hindlimb digital sensory nerve conduction velocity, and sciatic nerve concentrations of two major nonenzymatic antioxidants, glutathione and ascorbate, were reduced in diabetic versus control rats, and these changes were prevented in diabetic rats treated with fidarestat. Fidarestat prevented the diabetes-induced increase in nitrotyrosine (a marker of peroxynitrite-induced injury) and poly(ADP-ribose) immunoreactivities in sciatic nerve and retina. Fidarestat counteracted increased superoxide formation in aorta and epineurial vessels and in in vitro studies using hyperglycemia-exposed endothelial cells, and the DCF test\/flow cytometry confirmed the endothelial origin of this phenomenon. Fidarestat did not cause direct inhibition of PARP activity in a cell-free system containing PARP and NAD+ but did counteract high-glucose\u2013induced PARP activation in Schwann cells. In conclusion, aldose reductase inhibition counteracts diabetes-induced nitrosative stress and PARP activation in sciatic nerve and retina. These findings reveal the new beneficial properties of fidarestat, thus further justifying the ongoing clinical trials of this specific, potent, and low-toxic ARI.<\/jats:p>","DOI":"10.2337\/diabetes.54.1.234","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":131,"title":["Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications"],"prefix":"10.2337","volume":"54","author":[{"given":"Irina G.","family":"Obrosova","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"},{"name":"Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Pacher","sequence":"additional","affiliation":[{"name":"Laboratory of Physiological Studies, National Institutes of Health\/National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo\u0301","sequence":"additional","affiliation":[{"name":"Inotek Pharmaceuticals, Beverly, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Zsengeller","sequence":"additional","affiliation":[{"name":"Inotek Pharmaceuticals, Beverly, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hirooka","sequence":"additional","affiliation":[{"name":"Drug Development Research Laboratories, Sanwa Kagaku Kenkyusho, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Yorek","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031209003098500_R1","doi-asserted-by":"crossref","unstructured":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA\u2008287:2563\u20132569,2002","DOI":"10.1001\/jama.287.19.2563"},{"key":"2022031209003098500_R2","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet\u2008352:837\u2013853,1998","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2022031209003098500_R3","doi-asserted-by":"crossref","unstructured":"Oates PJ, Mylari BL: Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin Investig Drugs\u20088:2095\u20132119,1999","DOI":"10.1517\/13543784.8.12.2095"},{"key":"2022031209003098500_R4","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ: An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J\u200816:123\u2013125,2002","DOI":"10.1096\/fj.01-0603fje"},{"key":"2022031209003098500_R5","doi-asserted-by":"crossref","unstructured":"Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T: Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. J Diabetes Complications\u200817:374\u2013379,2003","DOI":"10.1016\/S1056-8727(02)00193-9"},{"key":"2022031209003098500_R6","doi-asserted-by":"crossref","unstructured":"Thornalley PJ: Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol\u200850:37\u201357,2002","DOI":"10.1016\/S0074-7742(02)50072-6"},{"key":"2022031209003098500_R7","unstructured":"Vlassara H, Palace MR: Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med\u200870:232\u2013241,2003"},{"key":"2022031209003098500_R8","doi-asserted-by":"crossref","unstructured":"Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N: A protein kinase C-\u03b2\u2013selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes\u200848:2090\u20132095,1999","DOI":"10.2337\/diabetes.48.10.2090"},{"key":"2022031209003098500_R9","doi-asserted-by":"crossref","unstructured":"Way KJ, Katai N, King GL: Protein kinase C and the development of diabetic vascular complications. Diabet Med\u200818:945\u2013959,2001","DOI":"10.1046\/j.0742-3071.2001.00638.x"},{"key":"2022031209003098500_R10","doi-asserted-by":"crossref","unstructured":"Obrosova IG: How does glucose generate oxidative stress in peripheral nerve?Int Rev Neurobiol\u200850:3\u201335,2002","DOI":"10.1016\/S0074-7742(02)50071-4"},{"key":"2022031209003098500_R11","doi-asserted-by":"crossref","unstructured":"Pennathur S, Heinecke JW: Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy. Front Biosci\u20089:565\u2013574,2004","DOI":"10.2741\/1257"},{"key":"2022031209003098500_R12","doi-asserted-by":"crossref","unstructured":"Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Fernyhough P, Tomlinson DR: A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J\u200815:2508\u20132514,2001","DOI":"10.1096\/fj.01-0253hyp"},{"key":"2022031209003098500_R13","doi-asserted-by":"crossref","unstructured":"Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C: Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med\u20087:108\u2013113,2001","DOI":"10.1038\/83241"},{"key":"2022031209003098500_R14","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJ: Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes\u200853:711\u2013720,2004","DOI":"10.2337\/diabetes.53.3.711"},{"key":"2022031209003098500_R15","doi-asserted-by":"crossref","unstructured":"Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J\u200818:1450\u20131452,2004","DOI":"10.1096\/fj.03-1476fje"},{"key":"2022031209003098500_R16","doi-asserted-by":"crossref","unstructured":"Lou MF, Dickerson JE Jr, Garadi R, York BM Jr: Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res\u200846:517\u2013530,1988","DOI":"10.1016\/S0014-4835(88)80009-5"},{"key":"2022031209003098500_R17","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Fathallah L: Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Diabetologia\u200843:1048\u20131055,2000","DOI":"10.1007\/s001250051488"},{"key":"2022031209003098500_R18","doi-asserted-by":"crossref","unstructured":"Lowitt S, Malone JI, Salem AF, Korthals J, Benford S: Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism\u200844:677\u2013680,1995","DOI":"10.1016\/0026-0495(95)90128-0"},{"key":"2022031209003098500_R19","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ: Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes\u200852:864\u2013871,2003","DOI":"10.2337\/diabetes.52.3.864"},{"key":"2022031209003098500_R20","doi-asserted-by":"crossref","unstructured":"El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB: High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci\u200844:3135\u20133143,2003","DOI":"10.1167\/iovs.02-1022"},{"key":"2022031209003098500_R21","doi-asserted-by":"crossref","unstructured":"Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature\u2008414:813\u2013820,2001.","DOI":"10.1038\/414813a"},{"key":"2022031209003098500_R22","doi-asserted-by":"crossref","unstructured":"Kato N, Mizuno K, Makino M, Suzuki T, Yagihashi S: Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats. Diabetes Res Clin Pract\u200850:77\u201385,2000","DOI":"10.1016\/S0168-8227(00)00164-9"},{"key":"2022031209003098500_R23","doi-asserted-by":"crossref","unstructured":"Price SA, Agthong S, Middlemas AB, Tomlinson DR: Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes\u200853:1851\u20131856,2004","DOI":"10.2337\/diabetes.53.7.1851"},{"key":"2022031209003098500_R24","doi-asserted-by":"crossref","unstructured":"Amano S, Yamagishi S, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M: Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem Biophys Res Commun\u2008299:183\u2013188,2002","DOI":"10.1016\/S0006-291X(02)02584-6"},{"key":"2022031209003098500_R25","doi-asserted-by":"crossref","unstructured":"Miwa K, Nakamura J, Hamada Y, Naruse K, Nakashima E, Kato K, Kasuya Y, Yasuda Y, Kamiya H, Hotta N: The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract\u200860:1\u20139,2003","DOI":"10.1016\/S0168-8227(02)00248-6"},{"key":"2022031209003098500_R26","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Fathallah L, Lang HJ, Greene DA: Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetologia\u200842:1187\u20131194,1999","DOI":"10.1007\/s001250051290"},{"key":"2022031209003098500_R27","doi-asserted-by":"crossref","unstructured":"Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA: Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes\u200850:1927\u20131937,2001","DOI":"10.2337\/diabetes.50.8.1927"},{"key":"2022031209003098500_R28","doi-asserted-by":"crossref","unstructured":"Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic neuropathy. Diabetes\u200853:2404\u20132411,2004","DOI":"10.2337\/diabetes.53.9.2404"},{"key":"2022031209003098500_R29","doi-asserted-by":"crossref","unstructured":"Kern TS, Engerman RL: Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res\u200813:863\u2013867,1994","DOI":"10.3109\/02713689409015087"},{"key":"2022031209003098500_R30","doi-asserted-by":"crossref","unstructured":"Kador PF, Takahashi Y, Wyman M, Ferris F 3rd: Diabetes like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol\u2008113:352\u2013354,1995","DOI":"10.1001\/archopht.1995.01100030108031"},{"key":"2022031209003098500_R31","doi-asserted-by":"crossref","unstructured":"Thomas TP, Porcellati F, Kato K, Stevens MJ, Sherman WR, Greene DA: Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells. J Clin Invest\u200893:2718\u20132724,1994","DOI":"10.1172\/JCI117286"},{"key":"2022031209003098500_R32","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Hosaka Y, Masterson JA, Jones SM, Thomas TP, Larkin DD: Down-regulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells. Am J Physiol\u2008277:E760\u2013E771,1999","DOI":"10.1152\/ajpendo.1999.277.4.E760"},{"key":"2022031209003098500_R33","doi-asserted-by":"crossref","unstructured":"Song Z, Fu DT, Chan YS, Leung S, Chung SS, Chung SK: Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress. Mol Cell Neurosci\u200823:638\u2013647,2003","DOI":"10.1016\/S1044-7431(03)00096-4"},{"key":"2022031209003098500_R34","doi-asserted-by":"crossref","unstructured":"Greene DA, Arezzo JC, Brown MB: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy: Zenarestat Study Group. Neurology\u200853:580\u2013591,1999","DOI":"10.1212\/WNL.53.3.580"},{"key":"2022031209003098500_R35","doi-asserted-by":"crossref","unstructured":"Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N, the SNK-860 Diabetic Neuropathy Study Group: Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care\u200824:1776\u20131782,2001","DOI":"10.2337\/diacare.24.10.1776"},{"key":"2022031209003098500_R36","doi-asserted-by":"crossref","unstructured":"Kador PF: The contributions of Jin H. Kinoshita to aldose reductase research. Exp Eye Res\u200850:615\u2013620,1990","DOI":"10.1016\/0014-4835(90)90102-Z"},{"key":"2022031209003098500_R37","doi-asserted-by":"crossref","unstructured":"Sima AA, Dunlap JA, Davidson EP, Wiese TJ, Lightle RL, Greene DA, Yorek MA: Supplemental myo-inositol prevents l-fucose-induced diabetic neuropathy. Diabetes\u200846:301\u2013306,1997","DOI":"10.2337\/diabetes.46.2.301"},{"key":"2022031209003098500_R38","doi-asserted-by":"crossref","unstructured":"Kuruvilla R, Eichberg J: Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor. J Neurochem\u200871:775\u2013783,1998","DOI":"10.1046\/j.1471-4159.1998.71020775.x"},{"key":"2022031209003098500_R39","doi-asserted-by":"crossref","unstructured":"Ohi T, Saita K, Furukawa S, Ohta M, Hayashi K, Matsukura S: Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis\/secretion of nerve growth factor. Exp Neurol\u2008151:215\u2013220,1998","DOI":"10.1006\/exnr.1998.6821"},{"key":"2022031209003098500_R40","doi-asserted-by":"crossref","unstructured":"Gupta S, Chough E, Daley J, Oates P, Tornheim K, Ruderman NB, Keaney JF Jr: Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. Am J Physiol Cell Physiol\u2008282:C560\u2013C566,2002","DOI":"10.1152\/ajpcell.00343.2001"},{"key":"2022031209003098500_R41","doi-asserted-by":"crossref","unstructured":"Virag L, Szabo E, Gergely P, Szabo C: Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention (Review). Toxicol Lett 140\u2013141:113\u2013124,2003","DOI":"10.1016\/S0378-4274(02)00508-8"},{"key":"2022031209003098500_R42","doi-asserted-by":"crossref","unstructured":"Lee AY, Chung SS: Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J\u200813:23\u201330 1999","DOI":"10.1096\/fasebj.13.1.23"},{"key":"2022031209003098500_R43","doi-asserted-by":"crossref","unstructured":"Phillips SA, Mirrlees D, Thornalley PJ: Modification of the glyoxalase system in streptozotocin-induced diabetic rats: effect of the aldose reductase inhibitor Statil. Biochem Pharmacol\u200846:805\u2013811,1993","DOI":"10.1016\/0006-2952(93)90488-I"},{"key":"2022031209003098500_R44","doi-asserted-by":"crossref","unstructured":"Beisswenger PJ, Howell SK, Nelson RG, Mauer M, Szwergold BS: Alpha-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans\u200831:1358\u20131363,2003","DOI":"10.1042\/bst0311358"},{"key":"2022031209003098500_R45","doi-asserted-by":"crossref","unstructured":"Nagaraj RH, Prabhakaram M, Ortwerth BJ, Monnier VM: Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes\u200843:580\u2013586,1994","DOI":"10.2337\/diabetes.43.4.580"},{"key":"2022031209003098500_R46","doi-asserted-by":"crossref","unstructured":"Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N: Epalrestat, an aldose reductase ihibitor, reduces the levels of N\u03b5-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care\u200823:1539\u20131544,2000","DOI":"10.2337\/diacare.23.10.1539"},{"key":"2022031209003098500_R47","doi-asserted-by":"crossref","unstructured":"Yan SF, Ramasamy R, Naka Y, Schmidt AM: Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res\u200893:1159\u20131169,2003","DOI":"10.1161\/01.RES.0000103862.26506.3D"},{"key":"2022031209003098500_R48","doi-asserted-by":"crossref","unstructured":"Keogh RJ, Dunlop ME, Larkins RG: Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism\u200846:41\u201347,1997","DOI":"10.1016\/S0026-0495(97)90165-7"},{"key":"2022031209003098500_R49","doi-asserted-by":"crossref","unstructured":"Yamagishi S, Uehara K, Otsuki S, Yagihashi S: Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice. J Neurochem\u200887:497\u2013507,2003","DOI":"10.1046\/j.1471-4159.2003.02011.x"},{"key":"2022031209003098500_R50","doi-asserted-by":"crossref","unstructured":"Nakamura J, Kasuya Y, Hamada Y, Nakashima E, Naruse K, Yasuda Y, Kato K, Hotta N: Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia\u200844:480\u2013487,2001","DOI":"10.1007\/s001250051646"},{"key":"2022031209003098500_R51","doi-asserted-by":"crossref","unstructured":"Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol\u200814 (Suppl. 3):S227\u2013S232,2003","DOI":"10.1097\/01.ASN.0000077407.90309.65"},{"key":"2022031209003098500_R52","doi-asserted-by":"crossref","unstructured":"Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes\u200851:514\u2013521,2002","DOI":"10.2337\/diabetes.51.2.514"},{"key":"2022031209003098500_R53","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ, Szabo C: Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med\u200814:55\u201364,2004","DOI":"10.3892\/ijmm.14.1.55"},{"key":"2022031209003098500_R54","doi-asserted-by":"crossref","unstructured":"Szabo C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A: Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation\u2008106:2680\u20132686,2002","DOI":"10.1161\/01.CIR.0000038365.78031.9C"},{"key":"2022031209003098500_R55","doi-asserted-by":"crossref","unstructured":"Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M: Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest\u2008112:1049\u20131057,2003","DOI":"10.1172\/JCI18127"},{"key":"2022031209003098500_R56","doi-asserted-by":"crossref","unstructured":"Ou P, Nourooz-Zadeh J, Tritschler HJ, Wolff S: Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid. Free Radic Res\u200825:337\u2013346,1996","DOI":"10.3109\/10715769609149056"},{"key":"2022031209003098500_R57","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA: Effects of DL-\u03b1-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes\u200849:1006\u20131015,2000","DOI":"10.2337\/diabetes.49.6.1006"},{"key":"2022031209003098500_R58","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ: Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia\u200844:1102\u20131010,2001","DOI":"10.1007\/s001250100631"},{"key":"2022031209003098500_R59","doi-asserted-by":"crossref","unstructured":"Li F, Szabo C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG: Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia\u200847:710\u2013717,2004","DOI":"10.1007\/s00125-004-1356-0"},{"key":"2022031209003098500_R60","doi-asserted-by":"crossref","unstructured":"Zatechka DS Jr, Kador PF, Garcia-Castineiras S, Lou MF: Diabetes can alter the signal transduction pathways in the lens of rats. Diabetes\u200852:1014\u20131022","DOI":"10.2337\/diabetes.52.4.1014"},{"key":"2022031209003098500_R61","doi-asserted-by":"crossref","unstructured":"Ha HC, Hester LD, Snyder SH: Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A\u200899:3270\u20133275,2002","DOI":"10.1073\/pnas.052712399"},{"key":"2022031209003098500_R62","doi-asserted-by":"crossref","unstructured":"Yang SH, Sharrocks AD, Whitmarsh AJ: Transcriptional regulation by the MAP kinase signaling cascades. Gene\u2008320:3\u201321,2003","DOI":"10.1016\/S0378-1119(03)00816-3"},{"key":"2022031209003098500_R63","doi-asserted-by":"crossref","unstructured":"Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG: Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J\u200817:1514\u20131516,2003","DOI":"10.1096\/fj.03-0013fje"},{"key":"2022031209003098500_R64","doi-asserted-by":"crossref","unstructured":"Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ: Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-l-carnitine administration. Diabetes\u200851:2619\u20132628,2002","DOI":"10.2337\/diabetes.51.8.2619"},{"key":"2022031209003098500_R65","doi-asserted-by":"crossref","unstructured":"Baumgartner-Parzer SM: Glycemia and regulation of endothelial adhesion molecules. Horm Metab Res\u200829:636\u2013638,1997","DOI":"10.1055\/s-2007-979116"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/54\/1\/234\/650800\/zdb00105000234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/54\/1\/234\/650800\/zdb00105000234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:23:49Z","timestamp":1667406229000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/54\/1\/234\/14689\/Aldose-Reductase-Inhibition-Counteracts-Oxidative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.54.1.234","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}